Back to search
Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Some tumors are difficult to treat with chemotherapy or radiation. One of the reasons is that areas of the tumor do not have many blood vessels, which makes it…
The goal of this clinical research study is to learn if utomilumab, when given with ISA101b, is able to shrink or slow the growth of tumors in patients with inc…
There are 2 phases in this study: Phase 1 (dose escalation) and Phase 2 (dose expansion). The goal of Phase 1 of this clinical research study is to find the hi…